Dekarsinohills Tablet – Fibroid Management & Cystic Care – Healthy Lifestyle – 900 Count

SKU:
DE041
Categories: Ayurvedic Medicine, Cell Care, Value Pack Ayurvedic Supplement
Description
Benefits:
- May Reduce Inflammation: It has anti-inflammatory properties that can help reduce the inflammation associated with fibroids and cysts.
- Supports Immunity: Guduchi extract strengthens the immune system, helping the body fight off worse conditions.
- Promotes Hormonal Balance: It helps to regulate hormonal levels, which may prevent the growth of unwanted cells.
- Detoxifies the Body: It has detoxifying properties that help in cleansing the body
Easy to Consume: Take 1 tablet twice a day preferably before meals or as recommended by the physician.
Legal Disclaimer: *These statements have not been evaluated by the FSSAI. This product is not intended to diagnose, treat, cure or prevent any disease.
Additional information
Pack Size |
pack of 1 ,pack of 2 ,pack of 4 ,pack of 5 |
---|
Shipping & Delivery
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “Dekarsinohills Tablet – Fibroid Management & Cystic Care – Healthy Lifestyle – 900 Count”
Related products
Add to Cart
This product has multiple variants. The options may be chosen on the product page
Add to Cart
This product has multiple variants. The options may be chosen on the product page
Add to Cart
This product has multiple variants. The options may be chosen on the product page
Add to Cart
This product has multiple variants. The options may be chosen on the product page
Add to Cart
This product has multiple variants. The options may be chosen on the product page
Add to Cart
This product has multiple variants. The options may be chosen on the product page
Add to Cart
This product has multiple variants. The options may be chosen on the product page
Add to Cart
This product has multiple variants. The options may be chosen on the product page
Reviews
Clear filtersThere are no reviews yet.